DRG 643

Medical DRG

Endocrine Disorders with MCC

TypeMedicalMDC10Dx Codes174

What is MS-DRG 643?

MS-DRG 643 is a Medical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 10 (MDC 10) with a Major Complication or Comorbidity (MCC). It maps to 174 ICD-10-CM diagnosis codes. For FY 2026 it carries a relative weight of 1.6461 with a geometric mean length of stay of 4.9 days and an arithmetic mean of 6.3 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Classification
Medical DRG
Diagnosis-driven grouping
Linked Codes
174 diagnosis
Billable Dx
100%
174 of 174 shown

FY 2026 Payment Data

Official values from Table 5 of the FY 2026 IPPS Final Rule (CMS).

Relative Weight
1.6461
Payment multiplier vs. average case (1.0)
Geometric Mean LOS
4.9 days
Used for transfer payment calculations
Arithmetic Mean LOS
6.3 days
Average length of stay
Post-Acute Transfer
Yes
Subject to the post-acute care transfer policy

Related MS-DRGs in This Severity Group

The same clinical condition is split into separate DRGs by complication severity. MCC pays more than CC, which pays more than no CC/MCC.

DRGTitleRel. WeightGMLOS
643Endocrine Disorders with MCCThis page1.64614.9 days
644Endocrine Disorders with CC1.02503.4 days
645Endocrine Disorders without CC/MCC0.76832.7 days

Linked ICD-10-CM Diagnosis Mappings

  • A18.7

    Tuberculosis of adrenal glands

    BillableChapter 1
  • A18.81

    Tuberculosis of thyroid gland

    BillableChapter 1
  • B67.31

    Echinococcus granulosus infection, thyroid gland

    BillableChapter 1
  • C72.9

    Malignant neoplasm of central nervous system, unspecified

    BillableChapter 2
  • C74.00

    Malignant neoplasm of cortex of unspecified adrenal gland

    BillableChapter 2
  • C74.01

    Malignant neoplasm of cortex of right adrenal gland

    BillableChapter 2
  • C74.02

    Malignant neoplasm of cortex of left adrenal gland

    BillableChapter 2
  • C74.10

    Malignant neoplasm of medulla of unspecified adrenal gland

    BillableChapter 2
  • C74.11

    Malignant neoplasm of medulla of right adrenal gland

    BillableChapter 2
  • C74.12

    Malignant neoplasm of medulla of left adrenal gland

    BillableChapter 2
  • C74.90

    Malignant neoplasm of unspecified part of unspecified adrenal gland

    BillableChapter 2
  • C74.91

    Malignant neoplasm of unspecified part of right adrenal gland

    BillableChapter 2
  • C74.92

    Malignant neoplasm of unspecified part of left adrenal gland

    BillableChapter 2
  • C75.0

    Malignant neoplasm of parathyroid gland

    BillableChapter 2
  • C75.1

    Malignant neoplasm of pituitary gland

    BillableChapter 2
  • C75.2

    Malignant neoplasm of craniopharyngeal duct

    BillableChapter 2
  • C75.8

    Malignant neoplasm with pluriglandular involvement, unspecified

    BillableChapter 2
  • C75.9

    Malignant neoplasm of endocrine gland, unspecified

    BillableChapter 2
  • C79.70

    Secondary malignant neoplasm of unspecified adrenal gland

    BillableChapter 2
  • C79.71

    Secondary malignant neoplasm of right adrenal gland

    BillableChapter 2
  • C79.72

    Secondary malignant neoplasm of left adrenal gland

    BillableChapter 2
  • D13.7

    Benign neoplasm of endocrine pancreas

    BillableChapter 2
  • D33.9

    Benign neoplasm of central nervous system, unspecified

    BillableChapter 2
  • D35.00

    Benign neoplasm of unspecified adrenal gland

    BillableChapter 2
  • D35.01

    Benign neoplasm of right adrenal gland

    BillableChapter 2
  • D35.02

    Benign neoplasm of left adrenal gland

    BillableChapter 2
  • D35.1

    Benign neoplasm of parathyroid gland

    BillableChapter 2
  • D35.2

    Benign neoplasm of pituitary gland

    BillableChapter 2
  • D35.3

    Benign neoplasm of craniopharyngeal duct

    BillableChapter 2
  • D35.7

    Benign neoplasm of other specified endocrine glands

    BillableChapter 2
  • D35.9

    Benign neoplasm of endocrine gland, unspecified

    BillableChapter 2
  • D44.0

    Neoplasm of uncertain behavior of thyroid gland

    BillableChapter 2
  • D44.10

    Neoplasm of uncertain behavior of unspecified adrenal gland

    BillableChapter 2
  • D44.11

    Neoplasm of uncertain behavior of right adrenal gland

    BillableChapter 2
  • D44.12

    Neoplasm of uncertain behavior of left adrenal gland

    BillableChapter 2
  • D44.2

    Neoplasm of uncertain behavior of parathyroid gland

    BillableChapter 2
  • D44.3

    Neoplasm of uncertain behavior of pituitary gland

    BillableChapter 2
  • D44.4

    Neoplasm of uncertain behavior of craniopharyngeal duct

    BillableChapter 2
  • D44.9

    Neoplasm of uncertain behavior of unspecified endocrine gland

    BillableChapter 2
  • D49.7

    Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system

    BillableChapter 2
  • E00.0

    Congenital iodine-deficiency syndrome, neurological type

    BillableChapter 4
  • E00.1

    Congenital iodine-deficiency syndrome, myxedematous type

    BillableChapter 4
  • E00.2

    Congenital iodine-deficiency syndrome, mixed type

    BillableChapter 4
  • E00.9

    Congenital iodine-deficiency syndrome, unspecified

    BillableChapter 4
  • E01.0

    Iodine-deficiency related diffuse (endemic) goiter

    BillableChapter 4
  • E01.1

    Iodine-deficiency related multinodular (endemic) goiter

    BillableChapter 4
  • E01.2

    Iodine-deficiency related (endemic) goiter, unspecified

    BillableChapter 4
  • E01.8

    Other iodine-deficiency related thyroid disorders and allied conditions

    BillableChapter 4
  • E02

    Subclinical iodine-deficiency hypothyroidism

    BillableChapter 4
  • E03.0

    Congenital hypothyroidism with diffuse goiter

    BillableChapter 4
  • E03.1

    Congenital hypothyroidism without goiter

    BillableChapter 4
  • E03.2

    Hypothyroidism due to medicaments and other exogenous substances

    BillableChapter 4
  • E03.3

    Postinfectious hypothyroidism

    BillableChapter 4
  • E03.8

    Other specified hypothyroidism

    BillableChapter 4
  • E03.9

    Hypothyroidism, unspecified

    BillableChapter 4
  • E04.0

    Nontoxic diffuse goiter

    BillableChapter 4
  • E04.2

    Nontoxic multinodular goiter

    BillableChapter 4
  • E04.8

    Other specified nontoxic goiter

    BillableChapter 4
  • E04.9

    Nontoxic goiter, unspecified

    BillableChapter 4
  • E07.0

    Hypersecretion of calcitonin

    BillableChapter 4
  • E07.1

    Dyshormogenetic goiter

    BillableChapter 4
  • E07.81

    Sick-euthyroid syndrome

    BillableChapter 4
  • E16.0

    Drug-induced hypoglycemia without coma

    BillableChapter 4
  • E16.1

    Other hypoglycemia

    BillableChapter 4
  • E16.3

    Increased secretion of glucagon

    BillableChapter 4
  • E16.8

    Other specified disorders of pancreatic internal secretion

    BillableChapter 4
  • E16.9

    Disorder of pancreatic internal secretion, unspecified

    BillableChapter 4
  • E16.A1

    Hypoglycemia level 1

    BillableChapter 4
  • E16.A2

    Hypoglycemia level 2

    BillableChapter 4
  • E16.A3

    Hypoglycemia level 3

    BillableChapter 4
  • E20.0

    Idiopathic hypoparathyroidism

    BillableChapter 4
  • E20.810

    Autosomal dominant hypocalcemia

    BillableChapter 4
  • E20.811

    Secondary hypoparathyroidism in diseases classified elsewhere

    BillableChapter 4
  • E20.812

    Autoimmune hypoparathyroidism

    BillableChapter 4
  • E20.818

    Other specified hypoparathyroidism due to impaired parathyroid hormone secretion

    BillableChapter 4
  • E20.819

    Hypoparathyroidism due to impaired parathyroid hormone secretion, unspecified

    BillableChapter 4
  • E20.89

    Other specified hypoparathyroidism

    BillableChapter 4
  • E20.9

    Hypoparathyroidism, unspecified

    BillableChapter 4
  • E21.0

    Primary hyperparathyroidism

    BillableChapter 4
  • E21.1

    Secondary hyperparathyroidism, not elsewhere classified

    BillableChapter 4
  • E21.2

    Other hyperparathyroidism

    BillableChapter 4
  • E21.3

    Hyperparathyroidism, unspecified

    BillableChapter 4
  • E21.4

    Other specified disorders of parathyroid gland

    BillableChapter 4
  • E21.5

    Disorder of parathyroid gland, unspecified

    BillableChapter 4
  • E22.0

    Acromegaly and pituitary gigantism

    BillableChapter 4
  • E22.1

    Hyperprolactinemia

    BillableChapter 4
  • E22.2

    Syndrome of inappropriate secretion of antidiuretic hormone

    BillableChapter 4
  • E22.8

    Other hyperfunction of pituitary gland

    BillableChapter 4
  • E22.9

    Hyperfunction of pituitary gland, unspecified

    BillableChapter 4
  • E23.0

    Hypopituitarism

    BillableChapter 4
  • E23.1

    Drug-induced hypopituitarism

    BillableChapter 4
  • E23.2

    Diabetes insipidus

    BillableChapter 4
  • E23.3

    Hypothalamic dysfunction, not elsewhere classified

    BillableChapter 4
  • E23.6

    Other disorders of pituitary gland

    BillableChapter 4
  • E23.7

    Disorder of pituitary gland, unspecified

    BillableChapter 4
  • E24.0

    Pituitary-dependent Cushing's disease

    BillableChapter 4
  • E24.1

    Nelson's syndrome

    BillableChapter 4
  • E24.2

    Drug-induced Cushing's syndrome

    BillableChapter 4
  • E24.3

    Ectopic ACTH syndrome

    BillableChapter 4
  • E24.4

    Alcohol-induced pseudo-Cushing's syndrome

    BillableChapter 4
  • E24.8

    Other Cushing's syndrome

    BillableChapter 4
  • E24.9

    Cushing's syndrome, unspecified

    BillableChapter 4
  • E25.0

    Congenital adrenogenital disorders associated with enzyme deficiency

    BillableChapter 4
  • E25.8

    Other adrenogenital disorders

    BillableChapter 4
  • E25.9

    Adrenogenital disorder, unspecified

    BillableChapter 4
  • E26.01

    Conn's syndrome

    BillableChapter 4
  • E26.02

    Glucocorticoid-remediable aldosteronism

    BillableChapter 4
  • E26.09

    Other primary hyperaldosteronism

    BillableChapter 4
  • E26.1

    Secondary hyperaldosteronism

    BillableChapter 4
  • E26.81

    Bartter's syndrome

    BillableChapter 4
  • E26.89

    Other hyperaldosteronism

    BillableChapter 4
  • E26.9

    Hyperaldosteronism, unspecified

    BillableChapter 4
  • E27.0

    Other adrenocortical overactivity

    BillableChapter 4
  • E27.1

    Primary adrenocortical insufficiency

    BillableChapter 4
  • E27.2

    Addisonian crisis

    BillableChapter 4
  • E27.3

    Drug-induced adrenocortical insufficiency

    BillableChapter 4
  • E27.40

    Unspecified adrenocortical insufficiency

    BillableChapter 4
  • E27.49

    Other adrenocortical insufficiency

    BillableChapter 4
  • E27.5

    Adrenomedullary hyperfunction

    BillableChapter 4
  • E27.8

    Other specified disorders of adrenal gland

    BillableChapter 4
  • E27.9

    Disorder of adrenal gland, unspecified

    BillableChapter 4
  • E29.0

    Testicular hyperfunction

    BillableChapter 4
  • E29.1

    Testicular hypofunction

    BillableChapter 4
  • E29.8

    Other testicular dysfunction

    BillableChapter 4
  • E29.9

    Testicular dysfunction, unspecified

    BillableChapter 4
  • E30.0

    Delayed puberty

    BillableChapter 4
  • E30.1

    Precocious puberty

    BillableChapter 4
  • E30.8

    Other disorders of puberty

    BillableChapter 4
  • E30.9

    Disorder of puberty, unspecified

    BillableChapter 4
  • E31.0

    Autoimmune polyglandular failure

    BillableChapter 4
  • E31.1

    Polyglandular hyperfunction

    BillableChapter 4
  • E31.20

    Multiple endocrine neoplasia [MEN] syndrome, unspecified

    BillableChapter 4
  • E31.21

    Multiple endocrine neoplasia [MEN] type I

    BillableChapter 4
  • E31.22

    Multiple endocrine neoplasia [MEN] type IIA

    BillableChapter 4
  • E31.23

    Multiple endocrine neoplasia [MEN] type IIB

    BillableChapter 4
  • E31.8

    Other polyglandular dysfunction

    BillableChapter 4
  • E31.9

    Polyglandular dysfunction, unspecified

    BillableChapter 4
  • E34.00

    Carcinoid syndrome, unspecified

    BillableChapter 4
  • E34.01

    Carcinoid heart syndrome

    BillableChapter 4
  • E34.09

    Other carcinoid syndrome

    BillableChapter 4
  • E34.1

    Other hypersecretion of intestinal hormones

    BillableChapter 4
  • E34.2

    Ectopic hormone secretion, not elsewhere classified

    BillableChapter 4
  • E34.30

    Short stature due to endocrine disorder, unspecified

    BillableChapter 4
  • E34.31

    Constitutional short stature

    BillableChapter 4
  • E34.321

    Primary insulin-like growth factor-1 (IGF-1) deficiency

    BillableChapter 4
  • E34.322

    Insulin-like growth factor-1 (IGF-1) resistance

    BillableChapter 4
  • E34.328

    Other genetic causes of short stature

    BillableChapter 4
  • E34.329

    Unspecified genetic causes of short stature

    BillableChapter 4
  • E34.39

    Other short stature due to endocrine disorder

    BillableChapter 4
  • E34.4

    Constitutional tall stature

    BillableChapter 4
  • E34.50

    Androgen insensitivity syndrome, unspecified

    BillableChapter 4
  • E34.51

    Complete androgen insensitivity syndrome

    BillableChapter 4
  • E34.52

    Partial androgen insensitivity syndrome

    BillableChapter 4
  • E34.8

    Other specified endocrine disorders

    BillableChapter 4
  • E34.9

    Endocrine disorder, unspecified

    BillableChapter 4
  • E89.0

    Postprocedural hypothyroidism

    BillableChapter 4
  • E89.2

    Postprocedural hypoparathyroidism

    BillableChapter 4
  • E89.3

    Postprocedural hypopituitarism

    BillableChapter 4
  • E89.5

    Postprocedural testicular hypofunction

    BillableChapter 4
  • E89.6

    Postprocedural adrenocortical (-medullary) hypofunction

    BillableChapter 4
  • Q89.1

    Congenital malformations of adrenal gland

    BillableChapter 17
  • Q89.2

    Congenital malformations of other endocrine glands

    BillableChapter 17
  • R94.6

    Abnormal results of thyroid function studies

    BillableChapter 18
  • R94.7

    Abnormal results of other endocrine function studies

    BillableChapter 18
  • S11.039S

    Unspecified open wound of vocal cord, sequela

    BillableChapter 19
  • S11.10XS

    Unspecified open wound of thyroid gland, sequela

    BillableChapter 19
  • S11.11XS

    Laceration without foreign body of thyroid gland, sequela

    BillableChapter 19
  • S11.12XS

    Laceration with foreign body of thyroid gland, sequela

    BillableChapter 19
  • S11.13XS

    Puncture wound without foreign body of thyroid gland, sequela

    BillableChapter 19
  • S11.14XS

    Puncture wound with foreign body of thyroid gland, sequela

    BillableChapter 19
  • S37.812A

    Contusion of adrenal gland, initial encounter

    BillableChapter 19
  • S37.813A

    Laceration of adrenal gland, initial encounter

    BillableChapter 19
  • S37.818A

    Other injury of adrenal gland, initial encounter

    BillableChapter 19
  • S37.819A

    Unspecified injury of adrenal gland, initial encounter

    BillableChapter 19